实用肝脏病杂志 ›› 2025, Vol. 28 ›› Issue (4): 609-612.doi: 10.3969/j.issn.1672-5069.2025.04.033

• 肝脏局灶性结节性增生 • 上一篇    下一篇

超声超微血管成像技术联合静脉超声造影检查诊断肝局灶性病变价值研究*

温朝美, 史海洋   

  1. 402160 重庆市 重庆医科大学附属永川医院超声科(温朝美);神经内科(史海洋)
  • 收稿日期:2024-10-31 出版日期:2025-07-10 发布日期:2025-07-14
  • 通讯作者: 史海洋,E-mail:1931828043@qq.com
  • 作者简介:温朝美,女,34岁,硕士研究生,主治医师。E-mail:19923605621@163.com
  • 基金资助:
    *重庆市科学技术委员会医学科研项目(编号:2021MSXM325)

Diagnostic efficacy of ultrasound fine vascular imaging technology and intravenous contrast-enhanced ultrasonography in patients with focal liver lesions

Wen Chaomei, Shi Haiyang   

  1. Department of Ultrasound, Yongchuan Hospital, Affiliated to Chongqing Medical University, 402160 Chongqing, China
  • Received:2024-10-31 Online:2025-07-10 Published:2025-07-14

摘要: 目的 评估超声超微血管成像技术(UFVIT)联合静脉超声造影(CEUS)检查诊断肝局灶性病变(FLL)性质的价值。方法 2021年5月~2024年4月我院诊治的95例FLL患者,均接受超声UFVIT联合CEUS检查,采用细针穿刺或手术后组织进行病理学检查诊断,应用受试者工作特征(ROC)曲线下面积(AUC)分析UFVIT联合CEUS检查的诊断效能。结果 在95例FLL患者中,组织病理学检查诊断良性病变51例和恶性病变44例;UFVIT诊断的灵敏度、特异度和准确度分别为81.8%、78.4%和80.0%,CEUS分别为68.2%、76.5%和72.6%,而两者联合诊断则分别为97.7%、96.1%和96.8%。结论 采用超声UFVIT联合CEUS检查诊断FLL的性质具有较高的准确性,可帮助临床医生鉴别肝脏良恶性病变,值得深入研究。

关键词: 肝脏局灶性病变, 超微血管成像技术, 超声造影, 诊断

Abstract: Objective The aim of this study was to assess diagnostic performance of ultrasound fine vascular imaging technology (UFVIT) and contrast-enhanced ultrasound (CEUS) in patients with focal liver lesions (FLL). Method This study was conducted on clinical data of 95 patients with FLL who admitted to our hospital between May 2021 and April 2024, and all patients underwent UFVIT and intravenous CEUS examinations. Pathological diagnosis was made on tissues from fine needle aspiration biopsy or from post-operational specimens. Area under receiver operating characteristic curve was applied to evaluate diagnostic efficacy. Result Of 95 patients with FLL, postoperative pathological examination found benign lesions in 51 cases, including focal nodular hyperplasia in 20 cases, hepatic hemangiomas in 31 cases, and malignant lesions in 44 cases, including Cholangiocarcinoma in5 cases and hepatocellular carcinoma in 39 cases; the sensitivity, specificity and accuracy by UFVIT were 81.8%, 78.4% and 80.0%, by CEUS were 68.2%, 76.5% and 72.6%, while by combination of the two methods were 97.7%, 96.1% and 和96.8%, much superior to any one method alone (P<0.05). Conclusion Microvascular imaging technology and intravenous contrast-enhanced ultrasonography has a high accuracy and reliability in distinguishing intrahepatic benign and malignant lesions in patients with FLL, which might help clinicians make a correct interventional measurement.

Key words: Hepatoma, Focal liver lesions, Ultrasound fine vascular imaging technology, Contrast-enhanced ultrasonography, Diagnosis